International Assets Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Buy |
724
+167
| +30% | +$87.7K | 0.03% | 531 |
|
|
2025
Q1 | $353K | Sell |
557
-9
| -2% | -$5.71K | 0.03% | 518 |
|
|
2024
Q4 | $405K | Sell |
566
-880,373
| -100% | -$630M | 0.03% | 481 |
|
|
2024
Q3 | $838 | Buy |
880,939
+879,916
| +86,013% | +$837 | ﹤0.01% | 1192 |
|
|
2024
Q2 | $1.08M | Buy |
1,023
+287
| +39% | +$302K | 0.1% | 187 |
|
|
2024
Q1 | $713K | Buy |
736
+63
| +9% | +$61.1K | 0.07% | 277 |
|
|
2023
Q4 | $591K | Sell |
673
-102
| -13% | -$89.6K | 0.08% | 293 |
|
|
2023
Q3 | $645K | Sell |
775
-29
| -4% | -$24.1K | 0.09% | 222 |
|
|
2023
Q2 | $578K | Buy |
804
+58
| +8% | +$41.7K | 0.08% | 245 |
|
|
2023
Q1 | $613K | Sell |
746
-15,019
| -95% | -$12.3M | 0.09% | 227 |
|
|
2022
Q4 | $564K | Buy |
15,765
+15,459
| +5,052% | +$553K | 0.06% | 324 |
|
|
2022
Q3 | $211K | Buy |
+306
| New | +$211K | 0.05% | 364 |
|
|
2021
Q2 | – | Sell |
-436
| Closed | -$208K | – | 1571 |
|
|
2021
Q1 | $208K | Buy |
436
+231
| +113% | +$110K | 0.02% | 504 |
|
|
2020
Q4 | $99K | Buy |
+205
| New | +$99K | 0.02% | 598 |
|